Sana Biotechnology, Inc.
SANA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001770121
No open-market purchases or sales by Sana Biotechnology, Inc. insiders were filed in the last 90 days; 211 institutions reported holding it in 13F filings for Q2 2026, worth $644.7M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Sana Biotechnology, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Of which not filed for Q2 2024 | Q2 2024 | Change |
|---|---|---|---|---|
| Holders | 154 | 1 | 148 | −5 |
| Shares | 146.3M | 124.6K | 148.3M | +2.10M (+1.4%) |
| Value | $1.46B | $1.25M | $810.3M | −$651.4M (−44.6%) |
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (21)
Institutions that held Sana Biotechnology, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Voloridge Investment Management, LLC | 616,587 | $3.37M | 0.01% |
| Mirae Asset Global ETFs Holdings Ltd. | 292,209 | $1.59M | 0.00% |
| Schonfeld Strategic Advisors LLC | 105,325 | $575.1K | 0.00% |
| Graham Capital Management, L.P. | 96,876 | $528.9K | 0.02% |
| Corebridge Financial, Inc. | 71,124 | $388.3K | 0.00% |
| Ensign Peak Advisors, Inc | 68,050 | $371.6K | 0.00% |
| Tudor Investment Corp Et Al | 51,974 | $283.8K | 0.00% |
| Sherbrooke Park Advisers LLC | 48,339 | $263.9K | 0.05% |
| Brevan Howard Capital Management LP | 46,296 | $252.8K | 0.02% |
| Omers Administration Corp | 35,600 | $194.4K | 0.00% |
| Alpine Global Management, LLC | 34,181 | $186.6K | 0.03% |
| Trexquant Investment LP | 30,178 | $164.8K | 0.00% |
| Two Sigma Advisers, LP | 19,100 | $104.3K | 0.00% |
| XTX Topco Ltd | 18,249 | $99.6K | 0.01% |
| Cetera Investment Advisers | 14,856 | $81.1K | 0.00% |
| Algert Global LLC | 13,286 | $72.5K | 0.00% |
| Virtu Financial LLC | 11,093 | $61.0K | 0.00% |
| Ronald Blue Trust, Inc. | 975 | $9.75K | 0.00% |
| Smartleaf Asset Management LLC | 597 | $3.22K | 0.00% |
| SRS Capital Advisors, Inc. | 150 | $819 | 0.00% |
| Optiver Holding B.V. | 117 | $639 | 0.00% |
Sold out (26)
Institutions that held Sana Biotechnology, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
Not filed for Q2 2024 yet (1)
Institutions that held Sana Biotechnology, Inc. at the end of Q1 2024 and haven't filed a 13F for Q2 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Credit Suisse AG | 124,622 | $1.25M |